Sign in
Taking people in FranceNo phase

Testing a communication aid tool for people with Parkinson's disease during doctor visits

Tests a new communication aid during visits with doctors in adults with Parkinson's disease.

Key facts

Who runs it
University Hospital, Lille
Where
Lille, FranceSee the site
Trial code
Registry title
Evaluation of a New Communication Aid Tool to Favor Global Patient Centered Care
Status
Recruiting
People taking part
120 people, planned
Started
21 Jul 2020
Expected to end
Dec 2026
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Consulting with PARKINSUN as communication aid-tool
  • Consulting without PARKINSUN as communication aid-tool
Record updated
23 December 2025

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with Parkinson's disease at any stage. It tests a communication tool used during visits to the family doctor and the neurologist.

Age
18 to 90 years
Sex
Men and women
Disease stage
Parkinson's disease, all stages

Main reasons for not taking part

  • Severe long-term neurological, mental or psychiatric illness
  • Memory or thinking problems that affect independence (MOCA score of 22 or less)
  • Not covered by a social security scheme
  • Under legal guardianship
  • Not fluent in French

The registry criteria, word for word

Show all 10 criteriaShow less

Who can take part

  • Adult men and women with all stages of PD
  • Without severe chronic neurological or mental or psychiatric pathology
  • Absence of cognitive impairment affecting autonomy (MDS criteria of dementia and MOCA > 22)
  • able to come (alone or accompanied) to consultation
  • Affiliate or beneficiary of a social security scheme
  • Subject having signed informed consent
  • Patient willing to comply with all procedures of the study and its duration

Who cannot take part

  • Administrative reasons: impossibility of receiving informed information, inability to participate in the whole study, absence of coverage by the social security system, refusal to sign consent
  • Subject under tutelage or curtailer
  • Subject not fluent in the French language to understand the instructions necessary to carry out the cognitive tests

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 90 years old?

Where in France

  • Hopital Roger Salengro, CHU LilleLille, FranceContact: David Devos, MD,PhDTaking people

About the trial

What the trial wants to find out

PARKINSUN is a new communication aid tool, expected to favor global patient centered care for PD patients during consultation with GPs and neurologists. Two groups of patients will be randomized to use or not PARKINSUN when they consult their physicians every 3 months during 7 months.

The 2 groups in the trial

  • consultation with ParkinsunTreatment being tested

    Treatment: Consulting with PARKINSUN as communication aid-tool

  • consultation as usual without ParkinsunExisting treatment, for comparison

    Treatment: Consulting without PARKINSUN as communication aid-tool

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Optimizing PD Patient's Health Pathways: Favoring Global, Patient Centered Care by a New Communication Aid Tool PARKINSUN
Plain-language title
Testing a communication aid tool for people with Parkinson's disease during doctor visitsGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Fit questions
Built from NCT04179695, who can take part
Record updated
23 December 2025